Bio Blast Pharma Aktie
WKN DE: A119KH / ISIN: IL0011319527
05.10.2020 15:54:46
|
Stock Alert: Enlivex Therapeutics Rise Continues
(RTTNews) - Shares of Enlivex Therapeutics Ltd. (ENLV) are up more than 30% Monday morning, continuing the momentum following positive Covid-19 drug results.
On October 1, the company had reported positive top-line results from the study of its Covid-19 drug candidate, Allocetra.
The stock gained nearly 60% in the last two days.
Enlivex stock is currently trading at $14.12, nearing to its 52-week high of $16.94.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bio Blast Pharma Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Bio Blast Pharma Ltd.mehr Analysen
Aktien in diesem Artikel
Bio Blast Pharma Ltd. | 0,87 | 4,82% |
|